Friday, Mar 7, 1997

Genentech Appoints Two New Vice Presidents

Joffre Baker to head Research Discovery and Paula Jardieu to oversee Pharmacological Sciences

South San Francisco, Calif. -- March 7, 1997 --

Genentech today announced the appointment of Joffre Baker, Ph.D. to vice president of Research Discovery and Paula Jardieu, Ph.D. to vice president of Pharmacological Sciences.

Dr. Baker will report to Dr. Dennis Henner, vice president of Research. Dr. Baker was previously the senior director of Research Discovery at Genentech where he oversaw the departments of Immunology, Neuroscience, Cardiovascular Research, and Molecular Oncology. He joined Genentech in 1988 as a senior scientist in the department of Cardiovascular Research before he was appointed to director of that department. Dr. Baker came to Genentech from the University of Kansas, Department of Biochemistry, where he was an assistant, and later an associate, professor. He received a Ph.D. in Biochemistry from the University of Hawaii, Honolulu, Hawaii, in 1977.

Dr. Jardieu will report to William Young, executive vice president. She joined Genentech in 1986 as a scientist in Molecular Biology from the Johns Hopkins University School of Medicine, where she held a faculty position. In her most recent position at Genentech, Dr. Jardieu was the senior director of Pharmacological Sciences. Prior to that, she was the research staff scientist and research team leader of Genentech's product in development for the treatment of allergic asthma, which was preceded by her position as senior scientist and research team leader of the company's anti-adhesion molecules in development. She will continue her role as the project team leader of the allergic asthma treatment in development. Dr. Jardieu received a Ph.D. in Microbiology and an M.S. in Biochemistry from Michigan State University, East Lansing, Michigan.

Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures, and markets human pharmaceuticals for unmet medical needs. The company has headquarters in South San Francisco, California and is traded on the New York and Pacific Stock Exchanges under the symbol GNE.

# # #